- Home
- CVAC vs OCSL Comparison
CVAC vs OCSL Comparison
Compare CVAC & OCSL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CVAC
- OCSL
- Stock Information
- Founded
- CVAC 2000
- OCSL 2007
- Country
- CVAC Germany
- OCSL United States
- Employees
- CVAC N/A
- OCSL N/A
- Industry
- CVAC Biotechnology: Pharmaceutical Preparations
- OCSL Finance: Consumer Services
- Sector
- CVAC Health Care
- OCSL Finance
- Exchange
- CVAC Nasdaq
- OCSL Nasdaq
- Market Cap
- CVAC 1.2B
- OCSL 1.2B
- IPO Year
- CVAC 2020
- OCSL 2008
- Fundamental
- Price
- CVAC $5.41
- OCSL $12.61
- Analyst Decision
- CVAC Hold
- OCSL Hold
- Analyst Count
- CVAC 3
- OCSL 6
- Target Price
- CVAC $6.83
- OCSL $15.20
- AVG Volume (30 Days)
- CVAC 404.4K
- OCSL 878.0K
- Earning Date
- CVAC 11-11-2025
- OCSL 11-18-2025
- Dividend Yield
- CVAC N/A
- OCSL 12.68%
- EPS Growth
- CVAC N/A
- OCSL N/A
- EPS
- CVAC 1.01
- OCSL 0.55
- Revenue
- CVAC $599,540,810.00
- OCSL $334,099,000.00
- Revenue This Year
- CVAC N/A
- OCSL N/A
- Revenue Next Year
- CVAC $23.83
- OCSL N/A
- P/E Ratio
- CVAC $5.40
- OCSL $23.08
- Revenue Growth
- CVAC 675.15
- OCSL N/A
- 52 Week Low
- CVAC $2.37
- OCSL $12.50
- 52 Week High
- CVAC $5.72
- OCSL $16.66
- Technical
- Relative Strength Index (RSI)
- CVAC 53.41
- OCSL 29.15
- Support Level
- CVAC $5.33
- OCSL $12.88
- Resistance Level
- CVAC $5.45
- OCSL $13.18
- Average True Range (ATR)
- CVAC 0.03
- OCSL 0.23
- MACD
- CVAC 0.01
- OCSL -0.03
- Stochastic Oscillator
- CVAC 66.10
- OCSL 1.60
About CVAC CureVac N.V.
CureVac NV is a biopharmaceutical company headquartered in Germany that is developing a new class of transformative medicines based on messenger ribonucleic acid (mRNA) that has the potential to improve the lives of people. CureVac had a collaboration with GSK to develop second-generation seasonal influenza and COVID-19 vaccines and an avian influenza vaccine. The company's other pipeline candidates include mRNA vaccines for oncology and molecular therapies spanning tumors, liver, and ocular diseases.
About OCSL Oaktree Specialty Lending Corporation
Oaktree Specialty Lending Corp is a specialty finance company. The company provides lending services and invests in small and mid-sized companies. The company's investment objective is to maximize its portfolio's total return by generating current income from debt investments, and to a lesser extent, capital appreciation from equity investments. The company provides customized, one-stop credit solutions to companies with limited access to public or syndicated capital markets.